CSIMarket
 


Cerevel Therapeutics Holdings Inc   (CERE)
Other Ticker:  
 


Cerevel Therapeutics Holdings Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cerevel Therapeutics Holdings Inc's ROI in the third quarter of 2023?
Cerevel Therapeutics Holdings Inc recorded a cumulative net loss of $-393 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -46.44%.

Within the Healthcare sector 536 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2023 quarter, so far to 3835, from total ROI ranking in the second quarter of 2023 at 3983.

Definition and Formula of Return on Investment


Return On Investment (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Investment Change -28.11 % 53.5 % 48.72 % 46.24 % -
Y / Y Net Income Change - - - - -
Investment (TTM) in Millions 743 829 867 945 1,034
Return On Investment (TTM) -46.44 % -43.16 % -45.77 % -45.33 % -60.21 %
CERE's Overall Ranking # 3835 # 3983 # 4188 # 4699 # 4615
Seq. Investment Change -10.34 % -4.45 % -8.24 % -8.56 % 91.45 %
Seq. Net Income Change - - - - -
Net Income (TTM) in Millions -393 -397 -388 -352 -422




Return On Investment CERE's Ranking
Within: No.
Industry # 216
Sector # 537
Overall # 3835

Return On Investment Statistics
High Average Low
-41.46 %
-120.17 %
-316.66 %
(Jun 30 2023)   (Nov 30 2015)







Financial Statements
Cerevel Therapeutics Holdings Inc's III. Quarter Investments $ 743 Millions CERE's Balance sheet
Cerevel Therapeutics Holdings Inc's III. Quarter Income $ -96 Millions Quarterly CERE's Income Statement
CERE's Income by Division See CERE's Income by Division


CERE Annual Return On Investment (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Aug 31 2015)
2015
(Aug 31 2014)
2014
Total Investments in Millions 945 646 416 6 28
Y / Y Investment Growth 46.24 % 55.48 % 6946.19 % -78.7 % -16.51 %
Net Income in Millions -352 -225 -144 -28 -29
Y / Y Net Income Growth - - - - -
Annual Return On Investment -37.19 % -34.86 % -34.73 % -477.22 % -105.84 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CERE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for CERE's Competitors
Roi for Cerevel Therapeutics Holdings Inc's Suppliers
Return On Investment for CERE's Customers

Other Ratios
CERE's Roa CERE's Inventory Turnover Ratio CERE's Growth Rates CERE's Dividend Statistics
CERE's Profitability Ratios CERE's Asset Turnover Ratio CERE's Dividend Growth
CERE's Roe CERE's Valuation Ratios CERE's Financial Strength Ratios CERE's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI


Date modified: 2023-11-02T13:31:04+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com